The dynorphin/κ-opioid receptor system and its role in psychiatric disorders (Q37946259)

25 August 2017

The dynorphin/κ-opioid receptor system and its role in psychiatric disorders (English)

1 reference

25 August 2017

0 references

0 references

H A Tejeda

1

1 reference

25 August 2017

T S Shippenberg

series ordinal

2

1 reference

25 August 2017

R Henriksson

series ordinal

3

1 reference

25 August 2017

language of work or name

1 reference

16 October 2011

1 reference

Cellular and Molecular Life Sciences

25 August 2017

1 reference

25 August 2017

69

1 reference

25 August 2017

857-896

1 reference

25 August 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1007/s00018-011-0844-x

25 August 2017

0 references

cites work

Nicotine addiction and comorbidity with alcohol abuse and mental illness

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Imaging of opioid receptors in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Dynorphin Is a Specific Endogenous Ligand of the κ Opioid Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

The dynorphin/kappa opioid receptor system: a new target for the treatment of addiction and affective disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Cloning and sequence analysis of cDNA for porcine β-neo-endorphin/dynorphin precursor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Porcine pituitary dynorphin: complete amino acid sequence of the biologically active heptadecapeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Dynorphin-(1-13), an extraordinarily potent opioid peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

A new opioid octapeptide related to dynorphin from porcine hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

α-Neo-endorphin: A “big” leu-enkephalin with potent opiate activity from porcine hypothalami

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Beta-neo-endorphin, a new hypothalamic "big" Leu-enkephalin of porcine origin: its purification and the complete amino acid sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Isolation and amino acid sequence analysis of a 4,000-dalton dynorphin from porcine pituitary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Rimorphin, a unique, naturally occurring [Leu]enkephalin-containing peptide found in association with dynorphin and alpha-neo-endorphin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Leumorphin is a novel endogenous opioid peptide derived from preproenkephalin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Structure-activity relationship studies of dynorphin A and related peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Dynorphin peptides differentially regulate the human kappa opioid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Non-opioid effects of dynorphins: possible role of the NMDA receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Pathobiology of dynorphins in trauma and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Dynorphin opioid peptides enhance acid-sensing ion channel 1a activity and acidosis-induced neuronal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Predominance of the amino-terminal octapeptide fragment of dynorphin in rat brain regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Expression of prodynorphin-derived peptides and mRNA in guinea-pig cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Prodynorphin-derived peptide expression in primate cortex and striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Defective prodynorphin processing in mice lacking prohormone convertase PC2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Developmental changes in opioid peptides and their receptors in Cpe(fat)/Cpe(fat) mice lacking peptide processing enzyme carboxypeptidase E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Cathepsin L participates in dynorphin production in brain cortex, illustrated by protease gene knockout and expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Prodynorphin processing by proprotein convertase 2. Cleavage at single basic residues and enhanced processing in the presence of carboxypeptidase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Proteases for processing proneuropeptides into peptide neurotransmitters and hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Prodynorphin storage and processing in axon terminals and dendrites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Dynorphin A(1-17) biotransformation in striatum of freely moving rats using microdialysis and matrix-assisted laser desorption/ionization mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Opiate Receptor: Demonstration in Nervous Tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Stereospecific Binding of the Potent Narcotic Analgesic [ 3 H]Etorphine to Rat-Brain Homogenate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Stereospecific Interaction Between Narcotic Analgesics and a Synaptic Plasma Membrane Fraction of Rat Cerebral Cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Molecular mechanisms and regulation of opioid receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

kappa-Opioid receptors also increase potassium conductance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Dynorphin A and cAMP-dependent protein kinase independently regulate neuronal calcium currents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Retrograde opioid signaling regulates glutamatergic transmission in the hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Modulatory effects of Gs-coupled excitatory opioid receptor functions on opioid analgesia, tolerance, and dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Kappa-opioid receptor signals through Src and focal adhesion kinase to stimulate c-Jun N-terminal kinases in transfected COS-7 cells and human monocytic THP-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Agonist-induced regulation and trafficking of kappa opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Comparison of pharmacological activities of three distinct kappa ligands (Salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Ligands regulate cell surface level of the human kappa opioid receptor by activation-induced down-regulation and pharmacological chaperone-mediated enhancement: differential effects of nonpeptide and peptide agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Chaperone-like effects of cell-permeant ligands on opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

N-Glycosylation of the human kappa opioid receptor enhances its stability but slows its trafficking along the biosynthesis pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Kinase cascades and ligand-directed signaling at the kappa opioid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Guidelines for human gene nomenclature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Isolation and structural organization of the human preproenkephalin B gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Isolation and characterization of the mouse homolog of the preprodynorphin (Pdyn) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Characterization of human prodynorphin gene transcripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Human prodynorphin gene generates several tissue-specific transcripts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Cloning and promoter mapping of mouse kappa opioid receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Structure and expression of a rat kappa opioid receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Redefinition of the human kappa opioid receptor gene (OPRK1) structure and association of haplotypes with opiate addiction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Mammalian RNA polymerase II core promoters: insights from genome-wide studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

An allelic variation in the human prodynorphin gene promoter alters stimulus-induced expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Multiple Functional Variants in cis Modulate PDYN Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

In vitro assays fail to predict in vivo effects of regulatory polymorphisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Molecular pathways of pain: Fos/Jun-mediated activation of a noncanonical AP-1 site in the prodynorphin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

A functional haplotype implicated in vulnerability to develop cocaine dependence is associated with reduced PDYN expression in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Genome-wide mapping of in vivo protein-DNA interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Ancient and recent positive selection transformed opioid cis-regulation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

A regulatory variation in OPRK1, the gene encoding the kappa-opioid receptor, is associated with alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Genome-wide analysis of chromatin regulation by cocaine reveals a role for sirtuins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

CpG islands in vertebrate genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Distinct DNA methylation patterns characterize differentiated human embryonic stem cells and developing human fetal liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Combinatorial patterns of histone acetylations and methylations in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Brain function and chromatin plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Complete sequencing and characterization of 21,243 full-length human cDNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Long non-coding RNAs: insights into functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Identification of genes related to Parkinson's disease using expressed sequence tags

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Analysis of the vertebrate insulator protein CTCF-binding sites in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

A CTCF-independent role for cohesin in tissue-specific transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

CTCF: master weaver of the genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Prodynorphin gene expression relates to NF-kappa B factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

[Leu5]enkephalin-encoding sequences are targets for a specific DNA-binding factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Genomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Regulation of prodynorphin gene expression in the hippocampus by glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

The regulation of hippocampal dynorphin by neural/neuroendocrine pathways: models for effects of aging on an opioid peptide system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

How do transcription factors select specific binding sites in the genome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Transcription factors in long-term memory and synaptic plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Ca2+-operated transcriptional networks: molecular mechanisms and in vivo models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Protein kinase A-dependent derepression of the human prodynorphin gene via differential binding to an intragenic silencer element

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

DREAM-alphaCREM interaction via leucine-charged domains derepresses downstream regulatory element-dependent transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Ca2+-dependent block of CREB-CBP transcription by repressor DREAM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Induction of the rat prodynorphin gene through Gs-coupled receptors may involve phosphorylation-dependent derepression and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

An essential role for DeltaFosB in the nucleus accumbens in morphine action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Regulation of gene expression and cocaine reward by CREB and ΔFosB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

A functional analysis of the CREB signaling pathway using HaloCHIP-chip and high throughput reporter assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

PeakSeq enables systematic scoring of ChIP-seq experiments relative to controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Genome-wide assessment of differential roles for p300 and CBP in transcription regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

DREAM is a critical transcriptional repressor for pain modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

DREAM ablation selectively alters THC place aversion and analgesia but leaves intact the motivational and analgesic effects of morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

New Myc-interacting proteins: a second Myc network emerges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

The Myc/Max/Mad network and the transcriptional control of cell behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Haematopoietic cell-fate decisions, chromatin regulation and ikaros

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Genetic mechanisms of behavior--don't forget about the transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Genomic targets of the human c-Myc protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Global mapping of c-Myc binding sites and target gene networks in human B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Tissue-specific transcriptional regulation has diverged significantly between human and mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Chromatin crosstalk in development and disease: lessons from REST

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Functional diversity for REST (NRSF) is defined by in vivo binding affinity hierarchies at the DNA sequence level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Communication between the synapse and the nucleus in neuronal development, plasticity, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

MeCP2, a key contributor to neurological disease, activates and represses transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Reciprocal actions of REST and a microRNA promote neuronal identity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Comparative genomics modeling of the NRSF/REST repressor network: from single conserved sites to genome-wide repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Comparative sequence analysis reveals an intricate network among REST, CREB and miRNA in mediating neuronal gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Neuron-restrictive silencer factor regulates the N-methyl-D-aspartate receptor 2B subunit gene in basal and ethanol-induced gene expression in fetal cortical neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Posttranscriptional regulation of BK channel splice variant stability by miR-9 underlies neuroadaptation to alcohol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Striatal microRNA controls cocaine intake through CREB signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Atypical prodynorphin gene expression in corticosteroid-producing cells of the rat adrenal gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Regulation of mouse kappa opioid receptor gene expression by different 3'-untranslated regions and the effect of retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Dual action of epidermal growth factor: extracellular signal-stimulated nuclear-cytoplasmic export and coordinated translation of selected messenger RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Netrin-1 signaling regulates de novo protein synthesis of kappa opioid receptor by facilitating polysomal partition of its mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

The adaptor Grb7 links netrin-1 signaling to regulation of mRNA translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Kappa opioid receptor contributes to EGF-stimulated neurite extension in development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Mouse kappa-opioid receptor mRNA differential transport in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Axonal mRNA transport and localized translational regulation of kappa-opioid receptor in primary neurons of dorsal root ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Copb1-facilitated axonal transport and translation of kappa opioid-receptor mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Distribution of dynorphin and enkephalin peptides in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Cortico-Basal Ganglia reward network: microcircuitry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Kappa 1 receptor mRNA distribution in the rat CNS: comparison to kappa receptor binding and prodynorphin mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Cloning and pharmacological characterization of a rat kappa opioid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Primary structure and functional expression of a guinea pig kappa opioid (dynorphin) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Major coexpression of kappa-opioid receptors and the dopamine transporter in nucleus accumbens axonal profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Dynorphinergic gaba neurons are a target of both typical and atypical antipsychotic drugs in the nucleus accumbens shell, central amygdaloid nucleus and thalamic central medial nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Kappa opioid receptor immunoreactivity in the nucleus accumbens and caudate-putamen is primarily associated with synaptic vesicles in axons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Endogenous kappa-opioid receptor systems regulate mesoaccumbal dopamine dynamics and vulnerability to cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Kappa Opioid Receptor Activation in the Nucleus Accumbens Inhibits Glutamate and GABA Release Through Different Mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Presynaptic kappa-opioid and muscarinic receptors inhibit the calcium-dependent component of evoked glutamate release from striatal synaptosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

The kappa-opioid agonist, U-69593, decreases acute amphetamine-evoked behaviors and calcium-dependent dialysate levels of dopamine and glutamate in the ventral striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Control of glutamate release by calcium channels and kappa-opioid receptors in rodent and primate striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

The glutamate homeostasis hypothesis of addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Dopaminergic Terminals in the Nucleus Accumbens But Not the Dorsal Striatum Corelease Glutamate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Vesicular glutamate transport promotes dopamine storage and glutamate corelease in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Glutamatergic signaling by mesolimbic dopamine neurons in the nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Basolateral amygdala stimulation evokes glutamate receptor-dependent dopamine efflux in the nucleus accumbens of the anaesthetized rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Influence of dopamine on limbic inputs to the nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Dopamine gating of forebrain neural ensembles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Dopamine D1 receptors have subcellular distributions conducive to interactions with prodynorphin in the rat nucleus accumbens shell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Opioid systems in the dentate gyrus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Presynaptic inhibition of glutamate release by neuropeptides: use-dependent synaptic modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Cocaine-induced intracellular signaling and gene expression are oppositely regulated by the dopamine D1 and D3 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

D1 dopamine receptor-deficient mouse: cocaine-induced regulation of immediate-early gene and substance P expression in the striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

The mesolimbic dopamine reward circuit in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Dynorphin and the pathophysiology of drug addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Modulation of pre- and postsynaptic dopamine D2 receptor function by the selective kappa-opioid receptor agonist U69593.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Functional relevance of neurotransmitter receptor heteromers in the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Molecular integration via allosteric interactions in receptor heteromers. A working hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Dynorphin-containing pathways in the substantia nigra and ventral tegmentum: a double labeling study using combined immunofluorescence and retrograde tracing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Convergent actions of orexin/hypocretin and CRF on dopamine neurons: Emerging players in addiction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Midbrain dopamine neurons: projection target determines action potential duration and dopamine D(2) receptor inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Both kappa and mu opioid agonists inhibit glutamatergic input to ventral tegmental area neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Adaptive gain and the role of the locus coeruleus-norepinephrine system in optimal performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

The neuropsychopharmacology of fronto-executive function: monoaminergic modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Dynorphin-containing axons directly innervate noradrenergic neurons in the rat nucleus locus coeruleus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Subcellular targeting of kappa-opioid receptors in the rat nucleus locus coeruleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

A highly selective κ-opioid receptor agonist, CI-977, reduces excitatory synaptic potentials in the rat locus coeruleus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Kappa opioid receptor activation depresses excitatory synaptic input to rat locus coeruleus neurons in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Presynaptic inhibition of diverse afferents to the locus ceruleus by kappa-opiate receptors: a novel mechanism for regulating the central norepinephrine system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Dynorphin and stress-related peptides in rat locus coeruleus: contribution of amygdalar efferents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Coexpression of prodynorphin and corticotrophin-releasing hormone in the rat central amygdala: evidence of two distinct endogenous opioid systems in the lateral division

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Immunohistochemical localization of the cloned kappa 1 receptor in the rat CNS and pituitary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Distinct distributions of mu, delta and kappa opioid receptor mRNA in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Expression of mu, kappa, and delta opioid receptor messenger RNA in the human CNS: a 33P in situ hybridization study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Kappa-Opioid and NMDA glutamate receptors are differentially targeted within rat medial prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Salvinorin A exerts opposite presynaptic controls on neurotransmitter exocytosis from mouse brain nerve terminals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Presynaptic opioid receptors on noradrenergic and serotonergic neurons in the human as compared to the rat neocortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Dopamine reuptake by norepinephrine neurons: exception or rule?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Dynorphin is contained within hippocampal mossy fibers: immunochemical alterations after kainic acid administration and colchicine-induced neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Endogenous dynorphins inhibit excitatory neurotransmission and block LTP induction in the hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Evaluation of the kappa-opioid receptor-selective tracer [(11)C]GR103545 in awake rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

[11C]-MeJDTic: a novel radioligand for kappa-opioid receptor positron emission tomography imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Psychotomimesis mediated by kappa opiate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

The effects of spiradoline (U-62066E), a kappa-opioid receptor agonist, on neuroendocrine function in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

The cardiovascular and central nervous system effects in the human of U-62066E. A selective opioid receptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Salvia divinorum: effects and use among YouTube users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Pattern of use and subjective effects of Salvia divinorum among recreational users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Role of cannabis and endocannabinoids in the genesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Persistent psychosis associated with salvia divinorum use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Adolescent salvia substance abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Involvement of kappa-opioid and endocannabinoid system on Salvinorin A-induced reward

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Depressive-like effects of the kappa opioid receptor agonist salvinorin A are associated with decreased phasic dopamine release in the nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Effects of kappa opioids in an assay of pain-depressed intracranial self-stimulation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Place preference conditioning reveals the involvement of D1-dopamine receptors in the motivational properties of mu- and kappa-opioid agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

SCH 23390 blocks drug-conditioned place-preference and place-aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Dual role of medial A10 dopamine neurons in affective encoding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

mu-Opioids disinhibit and kappa-opioids inhibit serotonin efflux in the dorsal raphe nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Brain reward circuitry beyond the mesolimbic dopamine system: a neurobiological theory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Stress-induced changes in brain Met-enkephalin, Leu-enkephalin and dynorphin concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Examining the intersection of sex and stress in modelling neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Nigrostriatal dopamine mediates the stimulatory effects of corticotropin releasing factor on methionine-enkephalin and dynorphin release from the rat neostriatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Antidepressant-like effects of kappa-opioid receptor antagonists in Wistar Kyoto rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Behavioural despair in rats: A new model sensitive to antidepressant treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Animal models of neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Prior activation of kappa opioid receptors by U50,488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Early experience as a determinant of adult behavioural responses to reward: the effects of repeated maternal separation in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Long-term effects of short and long periods of maternal separation on brain opioid peptide levels in male Wistar rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

The impact of postnatal environment on opioid peptides in young and adult male Wistar rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Early postnatal stress alters place conditioning to both mu- and kappa-opioid agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Molecular alterations in the neostriatum of human cocaine addicts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Prodynorphin mRNA expression is increased in the patch vs matrix compartment of the caudate nucleus in suicide subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Prodynorphin and kappa opioid receptor mRNA expression in the cingulate and prefrontal cortices of subjects diagnosed with schizophrenia or affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Subjects with major depression or bipolar disorder show reduction of prodynorphin mRNA expression in discrete nuclei of the amygdaloid complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

The role of CREB in depression and antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Prodynorphin-derived peptides are critical modulators of anxiety and regulate neurochemistry and corticosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

CRF1-R activation of the dynorphin/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Comparison of the kappa-opioid receptor antagonist DIPPA in tests of anxiety-like behavior between Wistar Kyoto and Sprague Dawley rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Review. Neurobiological mechanisms for opponent motivational processes in addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Reward processing by the opioid system in the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Reasons for increased substance use in psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Striatal and ventral pallidum dynorphin concentrations are markedly increased in human chronic cocaine users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Brain levels of neuropeptides in human chronic methamphetamine users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Role of brain dopamine in food reward and reinforcement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Reward system and addiction: what dopamine does and doesn't do.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Effects of repeated psychostimulant administration on the prodynorphin system activity and kappa opioid receptor density in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Kappa opioid receptor stimulation decreases amphetamine-induced behavior and neuropeptide mRNA expression in the striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Prodynorphin, proenkephalin and kappa opioid receptor mRNA responses to acute "binge" cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Cellular responses to psychomotor stimulant and neuroleptic drugs are abnormal in mice lacking the D1 dopamine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

The role of NMDA receptor systems in neuropeptide responses to stimulants of abuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Temporal upregulation of prodynorphin mRNA in the primate striatum after cocaine self-administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Contingency does not contribute to the effects of cocaine self-administration on prodynorphin and proenkephalin gene expression in the rat forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

The effects of D1 or D2 dopamine receptor blockade on zif/268 and preprodynorphin gene expression in rat forebrain following a short-term cocaine binge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Effect of single and repeated methamphetamine treatment on neurotransmitter release in substantia nigra and neostriatum of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Preprodynorphin mediates locomotion and D2 dopamine and mu-opioid receptor changes induced by chronic 'binge' cocaine administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Downregulation of kappa-opioid receptors in basolateral amygdala and septum of rats withdrawn for 14 days from an escalating dose "binge" cocaine administration paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Acute withdrawal from chronic escalating-dose binge cocaine administration alters kappa opioid receptor stimulation of [35S] guanosine 5'-O-[gamma-thio]triphosphate acid binding in the rat ventral tegmental area

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

A single cocaine exposure enhances both opioid reward and aversion through a ventral tegmental area-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Acute amphetamine exposure selectively desensitizes kappa-opioid receptors in the nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Exposure to the selective kappa-opioid receptor agonist salvinorin A modulates the behavioral and molecular effects of cocaine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Depletion of serotonin decreases the effects of the kappa-opioid receptor agonist U-69593 on cocaine-stimulated activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Effect of the kappa opioid agonist R-84760 on cocaine-induced increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Dissociable effects of the kappa-opioid receptor agonists bremazocine, U69593, and U50488H on locomotor activity and long-term behavioral sensitization induced by amphetamine and cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Effect of the endogenous kappa opioid agonist dynorphin A(1-17) on cocaine-evoked increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Sensitization to the conditioned rewarding effects of morphine and cocaine: differential effects of the kappa-opioid receptor agonist U69593.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

The kappa-opioid agonist U69,593 blocks cocaine-induced enhancement of brain stimulation reward

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Kappa-opioid receptor activation prevents alterations in mesocortical dopamine neurotransmission that occur during abstinence from cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Targeted disruption of cocaine-activated nucleus accumbens neurons prevents context-specific sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

The kappa-opioid receptor agonist U-69593 prevents cocaine-induced phosphorylation of DARPP-32 at Thr(34) in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Kappa opioid inhibition of morphine and cocaine self-administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Effects of cyclazocine on cocaine self-administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Regulation of cocaine-reinstated drug-seeking behavior by kappa-opioid receptors in the ventral tegmental area of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Inhibition of kappa opioid receptors attenuated increased cocaine intake in rats with extended access to cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Effects of the kappa-opioid receptor agonist, U69593, on the development of sensitization and on the maintenance of cocaine self-administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Activation of kappa opioid receptors decreases synaptic transmission and inhibits long-term potentiation in the basolateral amygdala of the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Attenuation of cocaine-induced reinstatement of drug seeking in squirrel monkeys: kappa opioid and serotonergic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Reinstatement of extinguished drug-taking behavior in rats: effect of the kappa-opioid receptor agonist, U69593.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Behavioral stress may increase the rewarding valence of cocaine-associated cues through a dynorphin/kappa-opioid receptor-mediated mechanism without affecting associative learning or memory retrieval mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Effectiveness of analogs of the kappa opioid receptor antagonist (3R)-7-hydroxy-N-((1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic) to reduce U50,488-induced

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Stress-induced reinstatement of cocaine seeking is mediated by the kappa opioid system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Reinstatement of cocaine place-conditioning prevented by the peptide kappa-opioid receptor antagonist arodyn

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Kappa agonist-induced reinstatement of cocaine seeking in squirrel monkeys: a role for opioid and stress-related mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Acute nicotine changes dynorphin and prodynorphin mRNA in the striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Enhanced vulnerability to the rewarding effects of nicotine during the adolescent period of development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Pharmacologic characterization of nicotine-induced conditioned place preference.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Nicotine modulation of stress-related peptide neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Repeated administration of cocaine, nicotine and ethanol: effects on preprodynorphin, preprotachykinin A and preproenkephalin mRNA expression in the dorsal and the ventral striatum of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Prodynorphin gene disruption increases the sensitivity to nicotine self-administration in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Effect of the selective kappa-opioid receptor antagonist JDTic on nicotine antinociception, reward, and withdrawal in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

A microdialysis profile of dynorphin A(1-8) release in the rat nucleus accumbens following alcohol administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Effects of acute ethanol on opioid peptide release in the central amygdala: an in vivo microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Repeated ethanol administration decreases prodynorphin biosynthesis in the rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Effect of ethanol on hypothalamic opioid peptides, enkephalin, and dynorphin: relationship with circulating triglycerides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Effect of chronic ethanol on enkephalin in the hypothalamus and extra-hypothalamic areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Ethanol withdrawal enhances the prodynorphin system activity in the rat nucleus accumbens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Repeated ethanol administration induces short- and long-term changes in enkephalin and dynorphin tissue concentrations in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Endogenous kappa opioid receptor systems modulate the responsiveness of mesoaccumbal dopamine neurons to ethanol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Ethanol alters the effect of kappa receptor ligands on dopamine release in the nucleus accumbens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Bremazocine reduces unrestricted free-choice ethanol self-administration in rats without affecting sucrose preference.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

The selective kappa-opioid receptor agonist U50,488H attenuates voluntary ethanol intake in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

A single injection of the kappa opioid antagonist norbinaltorphimine increases ethanol consumption in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Kappa-opioid receptor modulation of accumbal dopamine concentration during operant ethanol self-administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Dynorphin is a downstream effector of striatal BDNF regulation of ethanol intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Opioids in the hypothalamic paraventricular nucleus stimulate ethanol intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Medial dorsal hypothalamus mediates the inhibition of reward seeking after extinction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Kappa-opioid receptors and relapse-like drinking in long-term ethanol-experienced rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Endogenous kappa-opioid mediation of stress-induced potentiation of ethanol-conditioned place preference and self-administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Different roles of mu-, delta- and kappa-opioid receptors in ethanol-associated place preference in rats exposed to conditioned fear stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

A comparison between microwave irradiation and decapitation: basal levels of dynorphin and enkephalin and the effect of chronic morphine treatment on dynorphin peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

The effect of morphine tolerance dependence and abstinence on immunoreactive dynorphin (1-13) levels in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Regulation of gene expression by chronic morphine and morphine withdrawal in the locus ceruleus and ventral tegmental area.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

The locus coeruleus: A key nucleus where stress and opioids intersect to mediate vulnerability to opiate abuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Effect of morphine on dynorphin B and GABA release in the basal ganglia of rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Mu opioid receptor modulation of somatodendritic dopamine overflow: GABAergic and glutamatergic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Forebrain PENK and PDYN gene expression levels in three inbred strains of mice and their relationship to genotype-dependent morphine reward sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

A heroin-, but not a cocaine-expecting, self-administration state preferentially alters endogenous brain peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Mechanisms of withdrawal-associated increases in heroin self-administration: pharmacologic modulation of heroin vs food choice in heroin-dependent rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Endogenous kappa-opioid systems in opiate withdrawal: role in aversion and accompanying changes in mesolimbic dopamine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Precipitation of morphine withdrawal syndrome in rats by administration of mu-, delta- and kappa-selective opioid antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Morphine withdrawal precipitated by specific mu, delta or kappa opioid receptor antagonists: a c-Fos protein study in the rat central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Effects of JDTic, a selective kappa-opioid receptor antagonist, on the development and expression of physical dependence on morphine using a rat continuous-infusion model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Review. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Shift from goal-directed to habitual cocaine seeking after prolonged experience in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Phenotype of schizophrenia: a review and formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Neurobiology of dopamine in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Alterations of cortical GABA neurons and network oscillations in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Salvinorin A: the "magic mint" hallucinogen finds a molecular target in the kappa opioid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Clinical and biological markers for outcome in schizophrenia: a review of a longitudinal follow-up study in Uppsala schizophrenia research project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Bringing order to the glutamate chaos in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

The plant-derived hallucinogen, salvinorin A, produces ?-opioid agonist-like discriminative effects in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

The discriminative effects of the kappa-opioid hallucinogen salvinorin A in nonhuman primates: dissociation from classic hallucinogen effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Salvinorin A fails to substitute for the discriminative stimulus effects of LSD or ketamine in Sprague-Dawley rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Generalization of NMDA-receptor antagonists to the discriminative stimulus effects of kappa-opioid receptor agonists U-50,488H, but not TRK-820 in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Kappa opioid receptor activation disrupts prepulse inhibition of the acoustic startle in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

The effects of kappa-opioid receptor ligands on prepulse inhibition and CRF-induced prepulse inhibition deficits in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Developmental changes in the mRNA expression of neuropeptides and dopamine and glutamate receptors in neonates and adult rats after ventral hippocampal lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

The neonatal ventral hippocampal lesion model of schizophrenia: effects on dopamine and GABA mRNA markers in the rat midbrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

The role of executive cognitive functions in changing substance use: what we know and what we need to know

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Neurocognitive allied phenotypes for schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Sensitivity of the five-choice serial reaction time task to the effects of various psychotropic drugs in Sprague-Dawley rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Effects of kappa opioid receptor agonists on attention as assessed by a 5-choice serial reaction time task in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Microinjection of dynorphin into the hippocampus impairs spatial learning in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Hippocampal dynorphin B injections impair spatial learning in rats: a kappa-opioid receptor-mediated effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Transient activation of the CA3 Kappa opioid system in the dorsal hippocampus modulates complex memory processing in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Differential involvement of the mu and kappa opioid receptors in spatial learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Synaptic plasticity, memory and the hippocampus: a neural network approach to causality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Endogenous kappa opioid activation mediates stress-induced deficits in learning and memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Elevated dynorphin in the hippocampal formation of aged rats: relation to cognitive impairment on a spatial learning task

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Prodynorphin knockout mice demonstrate diminished age-associated impairment in spatial water maze performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Opioid receptor density changes in Alzheimer amygdala and putamen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Selective changes in mu, delta and kappa opioid receptor binding in certain limbic regions of the brain in Alzheimer's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Mu-, delta- and kappa-opioid receptor populations are differentially altered in distinct areas of postmortem brains of Alzheimer's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Differential alterations in adenosine A1 and kappa 1 opioid receptors in the striatum in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Endogenous opioids in frontal cortex of patients with Down syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Dysregulation of dynorphins in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Mesocortical dopamine modulation of executive functions: beyond working memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Involvement of kappa-opioid receptors and sigma receptors in memory function demonstrated using an antisense strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Genome-wide association studies for complex traits: consensus, uncertainty and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Human genetic variation and its contribution to complex traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Potentially functional polymorphism in the promoter region of prodynorphin gene may be associated with protection against cocaine dependence or abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Allelic variation in the human prodynorphin gene promoter and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Proposed schizophrenia-related gene polymorphism: expression of the Ser9Gly mutant human dopamine D3 receptor with the Semliki Forest virus system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

The ser9gly SNP in the dopamine D3 receptor causes a shift from cAMP related to PGE2 related signal transduction mechanisms in transfected CHO cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

The genetics of addictions: uncovering the genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Quantitative no-net-flux microdialysis permits detection of increases and decreases in dopamine uptake in mouse nucleus accumbens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Regulation of dopamine transporter function and cell surface expression by D3 dopamine receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Opioid neuropeptide genotypes in relation to heroin abuse: dopamine tone contributes to reversed mesolimbic proenkephalin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Association of the kappa-opioid system with alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Gene polymorphisms in prodynorphin (PDYN) are associated with episodic memory in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Can we identify genes for alcohol consumption in samples ascertained for heterogeneous purposes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Genome-wide association study of alcohol dependence implicates a region on chromosome 11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Response to Mitchell and Porteus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Single nucleotide polymorphism arrays: a decade of biological, computational and technological advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Integrated detection and population-genetic analysis of SNPs and copy number variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

An evaluation of HapMap sample size and tagging SNP performance in large-scale empirical and simulated data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

GWAS for psychiatric disease: is the framework built on a solid foundation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Uncovering the roles of rare variants in common disease through whole-genome sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Prodynorphin mutations cause the neurodegenerative disorder spinocerebellar ataxia type 23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Epigenomics reveals a functional genome anatomy and a new approach to common disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Lower CSF level of dynorphin(1–8) immunoreactivity in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0844-X

Roles of kappa-opioid receptor agonists in learning and memory impairment in animal models

21 January 2018

1 reference

12 December 2020

Cellular sites for dynorphin activation of kappa-opioid receptors in the rat nucleus accumbens shell

1 reference

12 December 2020

Frontal systems impairment in major depression.

1 reference

12 December 2020

A comparison of the role of dynorphin in the hippocampal mossy fiber pathway in guinea pig and rat.

1 reference

12 December 2020

Exposure to cocaine alters dynorphin-mediated regulation of excitatory synaptic transmission in nucleus accumbens neurons

1 reference

12 December 2020

Erratum: The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fibre synapses and modulates long-term potentiation

1 reference

12 December 2020

11C-GR103545, a radiotracer for imaging kappa-opioid receptors in vivo with PET: synthesis and evaluation in baboons.

1 reference

12 December 2020

Dynorphin opioids present in dentate granule cells may function as retrograde inhibitory neurotransmitters.

1 reference

12 December 2020

Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project

1 reference

12 December 2020

Emerging drugs for schizophrenia

1 reference

12 December 2020

Tissue-specific DNA methylation of the human prodynorphin gene in post-mortem brain tissues and PBMCs

1 reference

12 December 2020

Characterizing the site and mode of action of dynorphin at hippocampal mossy fiber synapses in the guinea pig.

1 reference

12 December 2020

Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors.

1 reference

12 December 2020

Developmental pathology, dopamine, stress and schizophrenia

1 reference

12 December 2020

Modulation of neurotransmitter release in the basal ganglia of the rat brain by dynorphin peptides.

1 reference

12 December 2020

Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats.

1 reference

12 December 2020

Kappa-opioid receptor activation modifies dopamine uptake in the nucleus accumbens and opposes the effects of cocaine.

1 reference

12 December 2020

Effects of U-50,488H on scopolamine-, mecamylamine- and dizocilpine-induced learning and memory impairment in rats.

1 reference

12 December 2020

The effects of morphine treatment and morphine withdrawal on the dynorphin and enkephalin systems in Sprague-Dawley rats

1 reference

12 December 2020

Toxic psychosis after intake of the hallucinogen salvinorin A

1 reference

12 December 2020

Levels of immunoreactive dynorphin A1-13 during development of morphine dependence in rats.

1 reference

12 December 2020

Spinal prodynorphin gene expression in collagen-induced arthritis: influence of the glucocorticosteroid budesonide

1 reference

12 December 2020

The role of mu- and kappa-opioid receptors in cocaine-induced conditioned place preference

1 reference

12 December 2020

International Union of Pharmacology. XII. Classification of opioid receptors.

1 reference

12 December 2020

Biological substrates of reward and aversion: a nucleus accumbens activity hypothesis.

1 reference

12 December 2020

The RNA superhighway: axonal RNA trafficking of kappa opioid receptor mRNA for neurite growth

1 reference

12 December 2020

Post-transcriptional regulation of mouse kappa-opioid receptor expression

1 reference

12 December 2020

Transcriptional and epigenetic regulation of opioid receptor genes: present and future

1 reference

12 December 2020

Social defeat stress-induced behavioral responses are mediated by the endogenous kappa opioid system

1 reference

12 December 2020

Stereospecific interaction between narcotic analgesics and a synaptic plasm a membrane fraction of rat cerebral cortex

1 reference

12 December 2020

Characterization of the rat prodynorphin gene

1 reference

12 December 2020

Dynorphin A and substance P in the cerebrospinal fluid of schizophrenic patients

1 reference

12 December 2020

Neuroendocrine and behavioral effects of the selective kappa agonist spiradoline in Tourette's syndrome: A pilot study

1 reference

12 December 2020

Somatodendritic dynorphin release: orchestrating activity patterns of vasopressin neurons

1 reference

12 December 2020

Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats.

1 reference

12 December 2020

Corticotropin-releasing factor stimulates the release of methionine-enkephalin and dynorphin from the neostriatum and globus pallidus of the rat: in vitro and in vivo studies

1 reference

12 December 2020

Polymorphism of Prodynorphin promoter is associated with schizophrenia in Chinese population

1 reference

12 December 2020

Prodynorphin Allelic Distribution in Scandinavian Chronic Alcoholics

1 reference

12 December 2020

Cell-specific effects of variants of the 68-base pair tandem repeat on prodynorphin gene promoter activity

1 reference

12 December 2020

Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect.

1 reference

12 December 2020

Dopamine release in the nucleus accumbens during heroin self-administration is modulated by kappa opioid receptors: an in vivo fast-cyclic voltammetry study

1 reference

12 December 2020

L-glutamate and gamma-aminobutyric acid efflux from rat cerebrocortical synaptosomes: modulation by kappa- and mu- but not delta- and opioid receptor like-1 receptors.

1 reference

12 December 2020

Prodynorphin peptide immunocytochemistry in rhesus monkey brain.

1 reference

12 December 2020

Prodynorphin transcripts and proteins differentially expressed and regulated in the adult human brain.

1 reference

12 December 2020

Differential effects of acute and chronic ethanol treatment on particular opioid peptide systems in discrete regions of rat brain and pituitary

1 reference

12 December 2020

The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis--II. Effects of dopamine D1 and D2 receptor agonists

1 reference

12 December 2020

Glutamate-dopamine interactions mediate the effects of psychostimulant drugs

1 reference

12 December 2020

Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies

1 reference

12 December 2020

Differential metabolism of dynorphins in substantia nigra, striatum, and hippocampus

1 reference

12 December 2020

Dynorphin-immunoreactive neurons in the central nervous system of the rat

1 reference

12 December 2020

Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses

1 reference

12 December 2020

Opioids excite dopamine neurons by hyperpolarization of local interneurons.

1 reference

12 December 2020

Studies of dual promoters of mouse kappa-opioid receptor gene.

1 reference

12 December 2020

Distribution of preproenkephalin, preprotachykinin A, and preprodynorphin mRNAs in the rat nucleus accumbens: effect of repeated administration of nicotine

1 reference

12 December 2020

Kappa opioid receptor inhibition of glutamatergic transmission in the nucleus accumbens shell

1 reference

12 December 2020

Altered sensitivity to rewarding and aversive drugs in mice with inducible disruption of cAMP response element-binding protein function within the nucleus accumbens

1 reference

12 December 2020

Systemic κ-opioid receptor antagonism by nor-binaltorphimine reduces dependence-induced excessive alcohol self-administration in rats

1 reference

12 December 2020

Insights into the receptor transcription and signaling: implications in opioid tolerance and dependence

1 reference

12 December 2020

Orexin (hypocretin) neurons contain dynorphin.

1 reference

12 December 2020

Differential agonist regulation of the human kappa-opioid receptor

1 reference

12 December 2020

Characterization of the prodynorphin and proenkephalin neuropeptide systems in rat hippocampus.

1 reference

12 December 2020

Analysis of laminar distribution of kappa opiate receptor in human cortex: comparison between schizophrenia and normal

1 reference

12 December 2020

Stimulus-specific hierarchy of enhancer elements within the rat prodynorphin promoter.

1 reference

12 December 2020

Delayed mesolimbic system alteration in a developmental animal model of schizophrenia.

1 reference

12 December 2020

Effects of kappa opioid agonists on cocaine- and food-maintained responding by rhesus monkeys

1 reference

12 December 2020

Kappa receptor activation attenuates L-trans-pyrrolidine-2,4-dicarboxylic acid-evoked glutamate levels in the striatum.

1 reference

12 December 2020

10.1007/S00018-011-0844-X

Identifiers

DOI

1 reference

25 August 2017

1 reference